Targeting Apoptosis Pathway with Natural Terpenoids: Implications for Treatment of Breast and Prostate Cancer

Overview

Journal Curr Drug Targets

Publisher Bentham Science Publishers

Specialty Pharmacology

Date 2010 Mar 20

PMID 20298150

Citations 38

Authors

Huanjie Yang

Q Ping Dou

Affiliations

Soon will be listed here.

Abstract

Terpenoids represent a large and diverse class of naturally occurring compounds found in a variety of fruits, vegetables and medicinal plants. Structurally some of the terpenoids are similar to human hormones. A diet rich in terpenoids is inversely related with the risk of chronic diseases including cancers. Breast and prostate cancers are hormone-related diseases and the second leading cause of female and male cancer mortality. Diterpenoid paclitaxel, and its semi-synthetic analogue docetaxel, have entered clinical use against established breast and prostate cancers. Here we reviewed potential molecular targets and biological properties of natural terpenoids, including monoterpenoids, diterpenoids, triterpenoids and tetraterpenoids, and their applications in treatment of human breast and prostate cancers. These terpenoids are able to inhibit tumor cell proliferation and induce tumor cell death by inhibiting multiple cancer-specific targets including the proteasome, NF-kappaB, and antiapoptotic protein Bcl-2. The efficacy of these terpenoids against breast or prostate cancer cells, as demonstrated in pre-clinical studies support clinical application of these naturally occurring terpenoids in treatment of hormone-related human cancers.

Citing Articles

Extraction efficiency and bioactive evaluation of Tamarix nilotica and Arthrocnemum macrostachyum extracts for anti-cancer potential.

Al Kaabi M, ElNaker N, Jan N, Ochsenkuhn M, Amin S, Yousef L PLoS One. 2025; 20(1):e0311567.

PMID: 39836644 PMC: 11750082. DOI: 10.1371/journal.pone.0311567.

Cytotoxic Effects of Plant Secondary Metabolites and Naturally Occurring Bioactive Peptides on Breast Cancer Model Systems: Molecular Mechanisms.

Zasheva D, Mladenov P, Zapryanova S, Gospodinova Z, Georgieva M, Alexandar I Molecules. 2024; 29(22).

PMID: 39598664 PMC: 11596968. DOI: 10.3390/molecules29225275.

Obesity Control and Supplementary Nutraceuticals as Cofactors of Brain Plasticity in Multiple Sclerosis Populations.

Ciumarnean L, Sarb O, Draghici N, Salagean O, Milaciu M, Orasan O Int J Mol Sci. 2024; 25(20).

PMID: 39456690 PMC: 11507128. DOI: 10.3390/ijms252010909.

Terpenes and Terpenoids Conjugated with BODIPYs: An Overview of Biological and Chemical Properties.

Stankova J, Jurasek M, Hajduch M, Dzubak P J Nat Prod. 2024; 87(4):1306-1319.

PMID: 38482846 PMC: 11061839. DOI: 10.1021/acs.jnatprod.3c00961.

α‑Phellandrene enhances the apoptosis of HT‑29 cells induced by 5‑fluorouracil by modulating the mitochondria‑dependent pathway.

Susanto A, Hartajanie L, Wu C Oncol Rep. 2024; 51(4).

PMID: 38456489 PMC: 10940876. DOI: 10.3892/or.2024.8720.

References

Ikezoe T, Chen S, Tong X, Heber D, Taguchi H, Koeffler H . Oridonin induces growth inhibition and apoptosis of a variety of human cancer cells. Int J Oncol. 2003; 23(4):1187-93. View

Goldberg A . Protein degradation and protection against misfolded or damaged proteins. Nature. 2003; 426(6968):895-9. DOI: 10.1038/nature02263. View

Nangia-Makker P, Tait L, Shekhar M, Palomino E, Hogan V, Piechocki M . Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum. Int J Cancer. 2007; 121(4):884-94. PMC: 3613994. DOI: 10.1002/ijc.22733. View

Mancuso A, Oudard S, Sternberg C . Effective chemotherapy for hormone-refractory prostate cancer (HRPC): present status and perspectives with taxane-based treatments. Crit Rev Oncol Hematol. 2006; 61(2):176-85. DOI: 10.1016/j.critrevonc.2006.09.001. View

Chen C, Welsbie D, Tran C, Baek S, Chen R, Vessella R . Molecular determinants of resistance to antiandrogen therapy. Nat Med. 2004; 10(1):33-9. DOI: 10.1038/nm972. View

Li B, Dou Q . Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci U S A. 2000; 97(8):3850-5. PMC: 18105. DOI: 10.1073/pnas.070047997. View

Dahan K, Fennal M, Kumar N . Lycopene in the prevention of prostate cancer. J Soc Integr Oncol. 2008; 6(1):29-36. View

Hieronymus H, Lamb J, Ross K, Peng X, Clement C, Rodina A . Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators. Cancer Cell. 2006; 10(4):321-30. DOI: 10.1016/j.ccr.2006.09.005. View

Zhu W, Ou Y, Li Y, Xiao R, Shu M, Zhou Y . A small-molecule triptolide suppresses angiogenesis and invasion of human anaplastic thyroid carcinoma cells via down-regulation of the nuclear factor-kappa B pathway. Mol Pharmacol. 2009; 75(4):812-9. DOI: 10.1124/mol.108.052605. View

10.

Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P . Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer. 2009; 127(1):172-84. DOI: 10.1002/ijc.25008. View

11.

Kiviharju T, Lecane P, Sellers R, Peehl D . Antiproliferative and proapoptotic activities of triptolide (PG490), a natural product entering clinical trials, on primary cultures of human prostatic epithelial cells. Clin Cancer Res. 2002; 8(8):2666-74. View

12.

Biswas D, Iglehart J . Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer. J Cell Physiol. 2006; 209(3):645-52. DOI: 10.1002/jcp.20785. View

13.

Vigushin D, Poon G, Boddy A, English J, Halbert G, Pagonis C . Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee. Cancer Chemother Pharmacol. 1998; 42(2):111-7. DOI: 10.1007/s002800050793. View

14.

Jia L, Shen H, Wantroba M, Khalid O, Liang G, Wang Q . Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol. 2006; 26(19):7331-41. PMC: 1592894. DOI: 10.1128/MCB.00581-06. View

15.

Lin R, Lo W, Wang Y, Chen C . A novel cytotoxic monoterpenoid from the leaves of Cinnamomum subavenium. Nat Prod Res. 2008; 22(12):1055-9. DOI: 10.1080/14786410802228637. View

16.

Irvin Jr W, Carey L . What is triple-negative breast cancer?. Eur J Cancer. 2008; 44(18):2799-805. DOI: 10.1016/j.ejca.2008.09.034. View

17.

Tamura K, Furihata M, Tsunoda T, Ashida S, Takata R, Obara W . Molecular features of hormone-refractory prostate cancer cells by genome-wide gene expression profiles. Cancer Res. 2007; 67(11):5117-25. DOI: 10.1158/0008-5472.CAN-06-4040. View

18.

Chalabi N, Satih S, Delort L, Bignon Y, Bernard-Gallon D . Expression profiling by whole-genome microarray hybridization reveals differential gene expression in breast cancer cell lines after lycopene exposure. Biochim Biophys Acta. 2007; 1769(2):124-30. DOI: 10.1016/j.bbaexp.2007.01.007. View

19.

Zhang R, Zhang P, Guo J, Yang D, Wang W, Zheng M . [Effects of triptolide on prostate carcinoma in mouse RM-1 cells]. Zhonghua Nan Ke Xue. 2007; 13(3):237-41. View

20.

Stan S, Hahm E, Warin R, Singh S . Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo. Cancer Res. 2008; 68(18):7661-9. PMC: 2562581. DOI: 10.1158/0008-5472.CAN-08-1510. View